Stratec Stock - Thursday technical picture around the 200-day line
18.06.2026 - 18:31:30 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 18:27 CET. Details in the imprint.
Stratec (DE000STRA555) is trading without fresh ad-hoc headlines on Thursday. The focus for investors is therefore on the chart setup around the 200-day moving average and recent volatility ranges, with the German diagnostics supplier moving in a relatively narrow corridor lately.
All news and background on Stratec stock
Stratec develops automation solutions for in-vitro diagnostics; our topic page bundles current figures, regulatory filings and price data for the stock.
What current filings show
There has been no new ad-hoc announcement or BaFin-registered market-sensitive release from Stratec today, and the investor relations section remains led by the May 2026 quarterly updates and presentation material.
The company most recently refreshed its financial data and outlook in its Q1/2026 communication, where management reiterated its focus on partner-driven growth in in-vitro diagnostics systems and confirmed its medium-term margin ambitions according to the latest investor presentation available on the Stratec website.
The Thursday chart setup
With no fresh headlines, Stratec shares are mainly guided by technical levels and general market sentiment on Thursday. Traders are watching the 200-day moving average as an important medium-term trend marker, alongside horizontal support from the spring trading range.
The stock has recently moved in a relatively tight band compared with the broader Standard & Poor's 500 index and European healthcare peers, reflecting a rather muted volatility pattern that keeps the focus on whether the current consolidation resolves higher or lower in the coming weeks.
How the company makes money
Stratec generates its revenue as an OEM partner for diagnostics groups, developing and producing automated analyzer systems, integrated software and consumables that customers brand under their own names for use in clinical laboratories and blood banks.
Where the stock trades today
Stratec shares (DE000STRA555) trade on Xetra at EUR 45.00 as of 06/18/2026, 18:15 CET.
Stratec at a glance
- Company: Stratec SE
- ISIN: DE000STRA555
- WKN: STRA55
- Ticker: SBS
- Venue: Xetra
- Price (as of 06/18/2026, 18:15 CET): 45.00 EUR
- Market cap: 550,000,000 EUR (as of 06/18/2026)
- Sector / Industry: Health Care / Life Sciences Tools & Services
- Index membership: not a member of a major headline index
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
